Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aliskiren effects on atherosclerotic biomarkers in CAD and T2DM
NCT00818779Phase 4Completed
- Sponsor
- Texas Tech University Health Sciences Center
- Start
- Jan 2008
- Primary completion
- Aug 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of aliskiren in coronary artery disease (CAD), sponsored by Texas Tech University Health Sciences Center. Started Jan 2008; status: completed.
02
Drugs
aliskiren
03
Conditions
coronary artery disease (CAD)
Beyond the preview
Go deeper on NCT00818779.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00818779.